Publication | Closed Access

Acute rejection under triple immunosuppressive therapy does not increase the risk of late first cadaveric renal allograft loss.

Transplant RejectionUrologyTransplantationKidney TransplantKidney TransplantationTransplantation MedicineImmunologyAutoimmunityAcute RejectionGraft SurvivalGraft RejectionImmunotherapyMedicineTriple Immunosuppressive TherapyNephrologyTransplant Immunology